Literature DB >> 2029056

The silence: the asbestos industry and early occupational cancer research--a case study.

D E Lilienfeld1.   

Abstract

To gain insight into corporate activities regarding the identification of occupational carcinogens earlier in this century, the actions of one industry, the asbestos industry, were reviewed. This industry, in concert with many of its insurers, systematically developed and then suppressed information on the carcinogenicity of asbestos. The development of warnings for those exposed to the asbestos was delayed. As a result, millions of workers were exposed to the carcinogen and hundreds of thousands died. These events are placed into the context of similar activities in other industries during this time.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2029056      PMCID: PMC1405162          DOI: 10.2105/ajph.81.6.791

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  11 in total

1.  ANTHONY J. LANZA, MD 1884-1964.

Authors:  D H GOLDSTEIN
Journal:  Arch Environ Health       Date:  1964-08

2.  ASBESTOS EXPOSURE AND NEOPLASIA.

Authors:  I J SELIKOFF; J CHURG; E C HAMMOND
Journal:  JAMA       Date:  1964-04-06       Impact factor: 56.272

3.  Public Health Weekly Reports for JANUARY 4, 1935.

Authors: 
Journal:  Public Health Rep       Date:  1935-01-04       Impact factor: 2.792

4.  Experimental studies of asbestosis.

Authors:  A J VORWALD; T M DURKAN; P C PRATT
Journal:  AMA Arch Ind Hyg Occup Med       Date:  1951-01

5.  A 'gift of God'?: The public health controversy over leaded gasoline during the 1920s.

Authors:  D Rosner; G Markowitz
Journal:  Am J Public Health       Date:  1985-04       Impact factor: 9.308

6.  Federal intervention in the Joplin silicosis epidemic, 1911-1916.

Authors:  A Derickson
Journal:  Bull Hist Med       Date:  1988       Impact factor: 1.314

7.  Corporate influence on threshold limit values.

Authors:  B I Castleman; G E Ziem
Journal:  Am J Ind Med       Date:  1988       Impact factor: 2.214

8.  Landmark perspective: Asbestos. An industrial asset with a health cost.

Authors:  W R Barclay
Journal:  JAMA       Date:  1984-07-06       Impact factor: 56.272

9.  Occupational exposure to asbestos: population at risk and projected mortality--1980-2030.

Authors:  W J Nicholson; G Perkel; I J Selikoff
Journal:  Am J Ind Med       Date:  1982       Impact factor: 2.214

10.  Projection of asbestos related diseases in the United States, 1985-2009. I. Cancer.

Authors:  D E Lilienfeld; J S Mandel; P Coin; L M Schuman
Journal:  Br J Ind Med       Date:  1988-05
View more
  8 in total

1.  Corporation-induced diseases, upstream epidemiologic surveillance, and urban health.

Authors:  René I Jahiel
Journal:  J Urban Health       Date:  2008-07       Impact factor: 3.671

2.  Statistical fallacies in orthopedic research.

Authors:  Abhaya Indrayan
Journal:  Indian J Orthop       Date:  2007-01       Impact factor: 1.251

3.  Tobacco industry issues management organizations: creating a global corporate network to undermine public health.

Authors:  Patricia A McDaniel; Gina Intinarelli; Ruth E Malone
Journal:  Global Health       Date:  2008-01-17       Impact factor: 4.185

Review 4.  Chemicals and cancer in humans: first evidence in experimental animals.

Authors:  J Huff
Journal:  Environ Health Perspect       Date:  1993-04       Impact factor: 9.031

Review 5.  Can laboratory animal carcinogenicity studies predict cancer in exposed children?

Authors:  D P Rall
Journal:  Environ Health Perspect       Date:  1995-09       Impact factor: 9.031

6.  Scientific integrity: critical issues in environmental health research.

Authors:  Domenico Franco Merlo; Kirsi Vahakangas; Lisbeth E Knudsen
Journal:  Environ Health       Date:  2008-06-05       Impact factor: 5.984

Review 7.  Asbestos-Related Disorders in Germany: Background, Politics, Incidence, Diagnostics and Compensation.

Authors:  Xaver Baur
Journal:  Int J Environ Res Public Health       Date:  2018-01-16       Impact factor: 3.390

Review 8.  An overview of the commercial determinants of health.

Authors:  Melissa Mialon
Journal:  Global Health       Date:  2020-08-17       Impact factor: 4.185

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.